MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

A

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

Search

NeoGenomics Inc

Closed

8.94 2.88

Overview

Share price change

24h

Current

Min

8.29

Max

9.07

Key metrics

By Trading Economics

Income

-19M

-45M

Sales

13M

181M

Profit margin

-24.867

Employees

2,200

EBITDA

-41M

-48M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+22.36% upside

Dividends

By Dow Jones

Next Earnings

4 Nov 2025

Market Stats

By TradingEconomics

Market Cap

172M

1B

Previous open

6.06

Previous close

8.94

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

NeoGenomics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

30 Sept 2025, 14:35 UTC

Major Market Movers

Robo.ai Shares Rise After $300 Million Investment From Burkhan Capital

25 Sept 2025, 16:56 UTC

Major Market Movers

PSQ Holdings Stock Slides on Plans to Launch Crypto Treasury Service

25 Sept 2025, 16:31 UTC

Major Market Movers

SharpLink Gaming Shares Fall on Plan to Tokenize Stock

25 Sept 2025, 08:03 UTC

Major Market Movers

Naver Surges on Talks With Cryptocurrency-Exchange Operator

23 Sept 2025, 18:02 UTC

Major Market Movers

Super League Shares Double After $10 Million Equity Investment From Evo Fund

23 Sept 2025, 13:09 UTC

Acquisitions, Mergers, Takeovers

Innovation Beverage Strikes Deal to Merge Into BlockFuel Energy

22 Sept 2025, 17:33 UTC

Major Market Movers

AgriFORCE Growing Systems Shares Double on New Blockchain Strategy

2 Oct 2025, 13:17 UTC

Acquisitions, Mergers, Takeovers

Bitcoin Depot: Acquisition Had No Material Impact on Reported 3Q Preliminary Results >BTM

2 Oct 2025, 13:16 UTC

Acquisitions, Mergers, Takeovers

Bitcoin Depot: Acquisition Brings U.S. Market Share to Roughly 30% >BTM

2 Oct 2025, 13:16 UTC

Acquisitions, Mergers, Takeovers

Bitcoin Depot: Acquisition Adds Over 500 Kiosks to Network >BTM

2 Oct 2025, 13:15 UTC

Acquisitions, Mergers, Takeovers

Bitcoin Depot Acquires Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

2 Oct 2025, 07:05 UTC

Market Talk

Global Equities Roundup: Market Talk

2 Oct 2025, 07:05 UTC

Market Talk

Bitcoin Rises Following Wall Street Rally -- Market Talk

1 Oct 2025, 23:12 UTC

Acquisitions, Mergers, Takeovers

Avalanche Treasury CEO is Bart Smith

1 Oct 2025, 23:11 UTC

Acquisitions, Mergers, Takeovers

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

1 Oct 2025, 23:07 UTC

Acquisitions, Mergers, Takeovers

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

1 Oct 2025, 23:06 UTC

Acquisitions, Mergers, Takeovers

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

1 Oct 2025, 23:04 UTC

Acquisitions, Mergers, Takeovers

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

1 Oct 2025, 14:01 UTC

Market Talk

Bitcoin Rises as Weak Jobs Data Boost Rate-Cut Bets -- Market Talk

1 Oct 2025, 07:27 UTC

Market Talk

Bitcoin Edges Lower as U.S. Government Shut Down Begins -- Market Talk

30 Sept 2025, 14:20 UTC

Major Market Movers

Robo.ai Shares Rise After $300M Investment From Burkhan Capital

30 Sept 2025, 06:51 UTC

Market Talk

Bitcoin Eases as Possible U.S. Government Shutdown Looms -- Market Talk

29 Sept 2025, 13:48 UTC

Market Talk

Seasonality Could Favor Bitcoin in Coming Months -- Market Talk

29 Sept 2025, 07:40 UTC

Market Talk

Bitcoin Recovers But Remains at Risk of Renewed Losses -- Market Talk

26 Sept 2025, 07:29 UTC

Market Talk

Bitcoin Stabilizes After Steep Falls; Focus Turns to U.S. PCE Data -- Market Talk

25 Sept 2025, 09:16 UTC

Market Talk

Bitcoin Falls as Investors Await U.S. Data -- Market Talk

24 Sept 2025, 12:50 UTC

Acquisitions, Mergers, Takeovers

Fitell Corp Completes Initial $10M Solana Purchase Following the First Closing Under $100M Financing Facility

24 Sept 2025, 06:55 UTC

Market Talk

Bitcoin Stays Weak After Powell Remarks -- Market Talk

23 Sept 2025, 17:47 UTC

Major Market Movers

Super League Shares Double After $10M Equity Investment From Evo Fund

22 Sept 2025, 20:36 UTC

Acquisitions, Mergers, Takeovers

Scaramucci-Backed Crypto Treasury Company Launches With $550 Million Fundraising Plan -- Update

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

22.36% upside

12 Months Forecast

Average 10.67 USD  22.36%

High 14 USD

Low 8 USD

Based on 11 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

5

Buy

6

Hold

0

Sell

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat